Most Popular
1. It’s a New Macro, the Gold Market Knows It, But Dead Men Walking Do Not (yet)- Gary_Tanashian
2.Stock Market Presidential Election Cycle Seasonal Trend Analysis - Nadeem_Walayat
3. Bitcoin S&P Pattern - Nadeem_Walayat
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
4.U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - Raymond_Matison
5. How to Profit from the Global Warming ClImate Change Mega Death Trend - Part1 - Nadeem_Walayat
7.Bitcoin Gravy Train Trend Forecast 2024 - - Nadeem_Walayat
8.The Bond Trade and Interest Rates - Nadeem_Walayat
9.It’s Easy to Scream Stocks Bubble! - Stephen_McBride
10.Fed’s Next Intertest Rate Move might not align with popular consensus - Richard_Mills
Last 7 days
US Presidential Election Year Stock Market Seasonal Trend - 29th Nov 24
Who controls the past controls the future: who controls the present controls the past - 29th Nov 24
Gold After Trump Wins - 29th Nov 24
The AI Stocks, Housing, Inflation and Bitcoin Crypto Mega-trends - 27th Nov 24
Gold Price Ahead of the Thanksgiving Weekend - 27th Nov 24
Bitcoin Gravy Train Trend Forecast to June 2025 - 24th Nov 24
Stocks, Bitcoin and Crypto Markets Breaking Bad on Donald Trump Pump - 21st Nov 24
Gold Price To Re-Test $2,700 - 21st Nov 24
Stock Market Sentiment Speaks: This Is My Strong Warning To You - 21st Nov 24
Financial Crisis 2025 - This is Going to Shock People! - 21st Nov 24
Dubai Deluge - AI Tech Stocks Earnings Correction Opportunities - 18th Nov 24
Why President Trump Has NO Real Power - Deep State Military Industrial Complex - 8th Nov 24
Social Grant Increases and Serge Belamant Amid South Africa's New Political Landscape - 8th Nov 24
Is Forex Worth It? - 8th Nov 24
Nvidia Numero Uno in Count Down to President Donald Pump Election Victory - 5th Nov 24
Trump or Harris - Who Wins US Presidential Election 2024 Forecast Prediction - 5th Nov 24
Stock Market Brief in Count Down to US Election Result 2024 - 3rd Nov 24
Gold Stocks’ Winter Rally 2024 - 3rd Nov 24
Why Countdown to U.S. Recession is Underway - 3rd Nov 24
Stock Market Trend Forecast to Jan 2025 - 2nd Nov 24
President Donald PUMP Forecast to Win US Presidential Election 2024 - 1st Nov 24
At These Levels, Buying Silver Is Like Getting It At $5 In 2003 - 28th Oct 24
Nvidia Numero Uno Selling Shovels in the AI Gold Rush - 28th Oct 24
The Future of Online Casinos - 28th Oct 24
Panic in the Air As Stock Market Correction Delivers Deep Opps in AI Tech Stocks - 27th Oct 24
Stocks, Bitcoin, Crypto's Counting Down to President Donald Pump! - 27th Oct 24
UK Budget 2024 - What to do Before 30th Oct - Pensions and ISA's - 27th Oct 24
7 Days of Crypto Opportunities Starts NOW - 27th Oct 24
The Power Law in Venture Capital: How Visionary Investors Like Yuri Milner Have Shaped the Future - 27th Oct 24
This Points To Significantly Higher Silver Prices - 27th Oct 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

What Are the 3 Stocks That Will Benefit from Covid-19?

Companies / Investing 2020 Dec 03, 2020 - 10:55 AM GMT

By: Submissions

Companies

The current coronavirus pandemic has had a massive effect on almost every aspect of the global stock market. In the United States, for instance, the stock market saw an enormous dip around March. This was the worst market crash ever since the infamous 1987 stock market dip in all the 120 years of its history. 

The majority of the shares in South Africa have also deteriorated in value as a result. However, despite all the pressure that companies continue to experience with this pandemic, some have enjoyed good returns. Institutions actively developing vaccines to help curb this menace have a high probability of reaping their exploits' benefits. 


Companies that can do well with remote work are also at an advantage in their pursuit of developing their potential. Here are three companies that are expected to gain from this global pandemic. 

Moderna

Among the industries set to benefit is the pharmaceutical sector at the forefront of fighting the virus. It is a fact that the first company that will get a breakthrough in developing an effective virus will be the biggest winner. Moderna saw its shares hike immediately and the firm revealed that it had already shared vaccine samples for verification by The National Institute of Allergy and Infectious Diseases (NIAID). 

Plans are underway to start trials to determine how viable it is and are set to be initialized in April of next year. One thing that helped Moderna develop this vaccine as quickly as it did was its innovative and efficient strategy in creating medicines. The firm uses RNA technology to do this, which gave it a significant edge in creating this vaccine. 

Interestingly, Moderna has not yet introduced a drug into the market, but investors still invest in the pharmaceutical company. As soon as the vaccine is deemed successful, you can expect that its market shares will only go up.

The Clorox Company 

Since most people are looking to accumulate consumer staples for the future, the Clorox Company will be in a prime position to make money from this development. The product line from this company is mainly bleach, cleaning products, among other sanitary components. 

The demand for its products is at an all-time high, so it wouldn't be surprising if they kept making massive sales globally. In 2020 alone, they have made 6.72 billion worth of sales. The company's shareholders will be happy with the returns on investment they will continue producing.  

Gilead Sciences 

Gilead Sciences is another company that is expected to be at an advantage within this period. The company's market shares have been on a constant rise ever since the news came out that it is in the advanced stages of researching remdesivir, an antiviral drug meant to curb the virus. This is essentially what the company is capitalizing on, which places it at a higher level than its competition. All this is if the drug is established to be a success. 

If it works, you can expect Gilead Sciences to make a lot of money, especially if countries approach the firm for supplies in case of another outbreak in the future. Information from the Center for Disease Control and Prevention (CDC) revealed that this antiviral medicine is already being administered to patients who are in grave condition. This practice is set to go up until there is a better alternative.

By Andrew Cioffi

© 2018 Copyright Andrew Cioffi - All Rights Reserved Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.


© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in